Reply to Patel et al.: Tempering the Clinical Effects of Early Myeloid-derived Suppressor Cell Expansion in Severe Sepsis and Septic Shock

Fabrice Uhel; Christophe Camus; Arnaud Gacouin; Jean-Marc Tadié; Yves Le Tulzo; Mikael Roussel; Karin Tarte

doi:10.1164/rccm.201709-1854LE

Reply to Patel et al.: Tempering the Clinical Effects of Early Myeloid-derived Suppressor Cell Expansion in Severe Sepsis and Septic Shock

Am J Respir Crit Care Med. 2018 Mar 1;197(5):678-679. doi: 10.1164/rccm.201709-1854LE.

Authors

Fabrice Uhel^{1

2

3}, Christophe Camus^{1

2}, Arnaud Gacouin^{1

2}, Jean-Marc Tadié^{1

2

3}, Yves Le Tulzo^{1

2

3}, Mikael Roussel^{1

2

3}, Karin Tarte^{1

2

3}

Affiliations

¹ 1 Centre Hospitalier Universitaire de Rennes Rennes, France.
² 2 Université Rennes 1 Rennes, France and.
³ 3 Établissement Français du Sang Bretagne Rennes, France.

PMID: 28984469
DOI: 10.1164/rccm.201709-1854LE

No abstract available

Publication types

Letter
Comment

MeSH terms

Cross Infection*
Granulocytes
Humans
Myeloid-Derived Suppressor Cells*
Sepsis*
Shock, Septic*